BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of single and multiple doses of phenytoin in man. 1974

L Lund, and G Alvan, and A Berlin, and B Alexanderson

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic

Related Publications

L Lund, and G Alvan, and A Berlin, and B Alexanderson
Pharmacokinetics of fluoride in man after single and multiple oral doses.
December 1977, European journal of clinical pharmacology,
L Lund, and G Alvan, and A Berlin, and B Alexanderson
Pharmacokinetics of fosfosal after single and multiple oral doses in man.
September 1988, International journal of clinical pharmacology, therapy, and toxicology,
L Lund, and G Alvan, and A Berlin, and B Alexanderson
Effect of 'Mentat' on the pharmacokinetics of single and multiple doses o phenytoin in rabbits.
June 1999, Neurology India,
L Lund, and G Alvan, and A Berlin, and B Alexanderson
[Pharmacokinetics of cloxazolam in man, after single and multiple oral doses (author's transl)].
January 1980, Therapie,
L Lund, and G Alvan, and A Berlin, and B Alexanderson
Pharmacokinetics of single and multiple ascending doses of the antiallergic agent tiacrilast in man.
January 1987, International journal of clinical pharmacology research,
L Lund, and G Alvan, and A Berlin, and B Alexanderson
Pharmacokinetics of tiropramide after single doses in man.
April 1986, Arzneimittel-Forschung,
L Lund, and G Alvan, and A Berlin, and B Alexanderson
Rimantadine pharmacokinetics after single and multiple doses.
May 1987, Antimicrobial agents and chemotherapy,
L Lund, and G Alvan, and A Berlin, and B Alexanderson
Pharmacokinetics of triflusal after single and repeated doses in man.
August 1990, International journal of clinical pharmacology, therapy, and toxicology,
L Lund, and G Alvan, and A Berlin, and B Alexanderson
Pharmacokinetics of methotrimeprazine after single and multiple doses.
April 1976, Clinical pharmacology and therapeutics,
L Lund, and G Alvan, and A Berlin, and B Alexanderson
Pharmacokinetics of clinafloxacin after single and multiple doses.
September 2001, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!